title: Correlation between serum levels of CA 125 and follicular loss after laparoscopic cystectomy in women with ovarian endometrioma.
abstract: OBJECTIVE
  To preoperatively predict follicular loss after laparoscopic cystectomy of ovarian endometriomas.
  
  
  METHODS
  Case-control study. (Canadian Task Force classification II-2).
  
  
  METHODS
  University hospital.
  
  
  METHODS
  Seventy-six women with ovarian endometrioma and 41 patients with nonendometriotic ovarian cysts who underwent laparoscopy.
  
  
  METHODS
  Sonographic findings and serum levels of CA 125 and CA 19.9 were recorded.
  
  
  RESULTS
  Considered parameters were compared with a histologic score, on the basis of the presence and morphologic features of follicles on the normal ovarian tissue adjacent to the cyst wall surgically removed. Serum levels of CA 125 and CA 19.9 were increased in patients with ovarian endometrioma (p <.001 and p <.01, respectively). Capsule wall thickness, presence of fibrosis, and follicles in the tissue surrounding the capsule were significantly increased in the study group (p <.01). CA 125 serum level was directly correlated to the histologic score (r = 0.46, p <.05) and to cyst diameter (r = 0.12, p = .01), whereas no correlation was found between CA 19.9 or cyst diameter and follicular score.
  
  
  CONCLUSIONS
  Our data suggest that the ovarian tissue inadvertently removed along with the endometrioma wall by laparoscopic stripping is due to pericystic fibrosis. Serum levels of CA 125 represent a useful parameter to predict follicular loss before surgery.
authors: Department of Obstetrics and Gynecology, University of Bari, Bari, Italy.
authors: Mario
authors: M
authors: Vicino
authors: Leonardo
authors: L
authors: Resta
authors: Marco
authors: M
authors: Scioscia
authors: Andrea
authors: A
authors: Marzullo
authors: Oronzo
authors: O
authors: Ceci
authors: Stefano
authors: S
authors: Bettocchi
mesh_terms: D000328:Adult; D018394:CA-125 Antigen / Q000097:blood*; D018395:CA-19-9 Antigen / Q000097:blood; D016022:Case-Control Studies; D004715:Endometriosis / Q000000981:diagnostic imaging / Q000601:surgery*; D005260:Female; D006801:Humans; D010535:Laparoscopy / Q000009:adverse effects; D010048:Ovarian Cysts / Q000000981:diagnostic imaging / Q000601:surgery*; D010049:Ovarian Diseases / Q000000981:diagnostic imaging / Q000601:surgery*; D006080:Ovarian Follicle / Q000293:injuries*; D014463:Ultrasonography
chemical_list: D018394:CA-125 Antigen; D018395:CA-19-9 Antigen